312 related articles for article (PubMed ID: 31402496)
1. mTOR and other effector kinase signals that impact T cell function and activity.
Myers DR; Wheeler B; Roose JP
Immunol Rev; 2019 Sep; 291(1):134-153. PubMed ID: 31402496
[TBL] [Abstract][Full Text] [Related]
2. mTOR signaling at the crossroads of environmental signals and T-cell fate decisions.
Huang H; Long L; Zhou P; Chapman NM; Chi H
Immunol Rev; 2020 May; 295(1):15-38. PubMed ID: 32212344
[TBL] [Abstract][Full Text] [Related]
3. The role and regulation of mTOR in T-lymphocyte function.
O'Brien TF; Zhong XP
Arch Immunol Ther Exp (Warsz); 2012 Jun; 60(3):173-81. PubMed ID: 22484804
[TBL] [Abstract][Full Text] [Related]
4. Mammalian target of rapamycin integrates diverse inputs to guide the outcome of antigen recognition in T cells.
Waickman AT; Powell JD
J Immunol; 2012 May; 188(10):4721-9. PubMed ID: 22556133
[TBL] [Abstract][Full Text] [Related]
5. mTOR signaling in the differentiation and function of regulatory and effector T cells.
Zeng H; Chi H
Curr Opin Immunol; 2017 Jun; 46():103-111. PubMed ID: 28535458
[TBL] [Abstract][Full Text] [Related]
6. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
[TBL] [Abstract][Full Text] [Related]
7. Natural killer group 2D and CD28 receptors differentially activate mammalian/mechanistic target of rapamycin to alter murine effector CD8+ T-cell differentiation.
McQueen B; Trace K; Whitman E; Bedsworth T; Barber A
Immunology; 2016 Mar; 147(3):305-20. PubMed ID: 26661515
[TBL] [Abstract][Full Text] [Related]
8. Cutting edge: distinct TCR- and CD28-derived signals regulate CD95L, Bcl-xL, and the survival of primary T cells.
Kerstan A; Hünig T
J Immunol; 2004 Feb; 172(3):1341-5. PubMed ID: 14734708
[TBL] [Abstract][Full Text] [Related]
9. Kidins220/ARMS associates with B-Raf and the TCR, promoting sustained Erk signaling in T cells.
Deswal S; Meyer A; Fiala GJ; Eisenhardt AE; Schmitt LC; Salek M; Brummer T; Acuto O; Schamel WW
J Immunol; 2013 Mar; 190(5):1927-35. PubMed ID: 23359496
[TBL] [Abstract][Full Text] [Related]
10. mTOR Promotes Antiviral Humoral Immunity by Differentially Regulating CD4 Helper T Cell and B Cell Responses.
Ye L; Lee J; Xu L; Mohammed AU; Li W; Hale JS; Tan WG; Wu T; Davis CW; Ahmed R; Araki K
J Virol; 2017 Feb; 91(4):. PubMed ID: 27974559
[TBL] [Abstract][Full Text] [Related]
11. The duration of T cell stimulation is a critical determinant of cell fate and plasticity.
Miskov-Zivanov N; Turner MS; Kane LP; Morel PA; Faeder JR
Sci Signal; 2013 Nov; 6(300):ra97. PubMed ID: 24194584
[TBL] [Abstract][Full Text] [Related]
12. SWAP-70-like adapter of T cells: a novel Lck-regulated guanine nucleotide exchange factor coordinating actin cytoskeleton reorganization and Ca2+ signaling in T cells.
Bécart S; Altman A
Immunol Rev; 2009 Nov; 232(1):319-33. PubMed ID: 19909373
[TBL] [Abstract][Full Text] [Related]
13. Visualizing TCR-induced POLKADOTS formation and NF-κB activation in the D10 T-cell clone and mouse primary effector T cells.
Paul S; Schaefer BC
Methods Mol Biol; 2015; 1280():219-38. PubMed ID: 25736751
[TBL] [Abstract][Full Text] [Related]
14. Recombinant TCR ligand induces early TCR signaling and a unique pattern of downstream activation.
Wang C; Mooney JL; Meza-Romero R; Chou YK; Huan J; Vandenbark AA; Offner H; Burrows GG
J Immunol; 2003 Aug; 171(4):1934-40. PubMed ID: 12902496
[TBL] [Abstract][Full Text] [Related]
15. TIM-3 Suppresses Anti-CD3/CD28-Induced TCR Activation and IL-2 Expression through the NFAT Signaling Pathway.
Tomkowicz B; Walsh E; Cotty A; Verona R; Sabins N; Kaplan F; Santulli-Marotto S; Chin CN; Mooney J; Lingham RB; Naso M; McCabe T
PLoS One; 2015; 10(10):e0140694. PubMed ID: 26492563
[TBL] [Abstract][Full Text] [Related]
16. The Regulatory Effects of mTOR Complexes in the Differentiation and Function of CD4
Wang P; Zhang Q; Tan L; Xu Y; Xie X; Zhao Y
J Immunol Res; 2020; 2020():3406032. PubMed ID: 32377533
[TBL] [Abstract][Full Text] [Related]
17. mTOR signaling in T cell immunity and autoimmunity.
Liu Y; Zhang DT; Liu XG
Int Rev Immunol; 2015 Jan; 34(1):50-66. PubMed ID: 25019278
[TBL] [Abstract][Full Text] [Related]
18. Activation of resting human primary T cells with chimeric receptors: costimulation from CD28, inducible costimulator, CD134, and CD137 in series with signals from the TCR zeta chain.
Finney HM; Akbar AN; Lawson AD
J Immunol; 2004 Jan; 172(1):104-13. PubMed ID: 14688315
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells potently purge latent HIV-1 beyond TCR-stimulation, activating the PI3K-Akt-mTOR pathway.
van Montfort T; van der Sluis R; Darcis G; Beaty D; Groen K; Pasternak AO; Pollakis G; Vink M; Westerhout EM; Hamdi M; Bakker M; van der Putten B; Jurriaans S; Prins JH; Jeeninga R; Thomas AAM; Speijer D; Berkhout B
EBioMedicine; 2019 Apr; 42():97-108. PubMed ID: 30824386
[TBL] [Abstract][Full Text] [Related]
20. TCR-independent CD30 signaling selectively induces IL-13 production via a TNF receptor-associated factor/p38 mitogen-activated protein kinase-dependent mechanism.
Harlin H; Podack E; Boothby M; Alegre ML
J Immunol; 2002 Sep; 169(5):2451-9. PubMed ID: 12193714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
